サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1789374

人工肺市場：製品種類別、患者の種類別、エンドユーザー別、地域別

Artificial Lung Market, By Product Type, By Patient Type, By End User, By Geography

出版日
ページ情報
英文 168 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
人工肺市場：製品種類別、患者の種類別、エンドユーザー別、地域別
出版日: 2025年07月16日
発行: Coherent Market Insights
ページ情報: 英文 168 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工肺市場は2025年に21億米ドルと推定され、2032年には41億2,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は10.1%で成長する見込みです。

分析範囲 分析詳細
基準年 2024年 市場規模 (2025年) 21億米ドル
実績データ 2020～2024年 予測期間 2025～2032年
予測期間のCAGR (2025～2032年) 10.10% 予測金額 (2032年) 41億2,000万米ドル

世界の人工肺市場は、より広範な医療機器産業の中でも重要なセグメントであり、重度の呼吸器疾患を抱える患者の肺機能を一時的または永続的に自然なものに置き換えるために設計された高度な生命維持技術に焦点を当てています。

人工肺は、体外膜型人工肺（ECMO）システムまたは機械的肺活量補助装置としても知られ、急性呼吸窮迫症候群（ARDS）、慢性閉塞性肺疾患（COPD）、肺塞栓症、およびその他の生命を脅かす呼吸不全に苦しむ患者にとって不可欠な治療ソリューションとして機能します。これらの洗練された生物医学的装置は、血液を酸素化し二酸化炭素を体外に排出することで機能し、健康な肺が通常担っているガス交換機能を効果的に実行します。

この市場には、膜型酸素吸入器、人工肺インプラント、装着型人工肺システムなど、さまざまな技術的アプローチがあり、それぞれが特定の患者のニーズや臨床シナリオに対応するように設計されています。呼吸器疾患の世界の有病率の増加、人口の高齢化、および呼吸器パンデミックの最近の影響により、人工肺市場は、クリティカルケアの課題に対処し、集中治療環境における患者の転帰を改善するための革新的なソリューションを求める医療提供者、医療機器メーカー、および投資家から大きな注目を集めています。

市場力学

世界の人工肺市場は、慢性閉塞性肺疾患、急性呼吸窮迫症候群、肺線維症などの呼吸器疾患の世界の有病率の高まりが主な原動力となっており、これらの疾患は世界全体で数百万人の患者を罹患させ、高度な呼吸補助技術に対する大きな需要を生み出しています。高齢者は呼吸器合併症の影響を受けやすく、集中治療が必要になるため、世界人口の高齢化は市場成長に大きく寄与しています。一方、生体適合性材料、小型化、ガス交換効率の改善などの技術進歩により、人工肺システムの性能と安全性が向上しています。

COVID-19の大流行は、呼吸補助装置の重要な必要性を浮き彫りにし、世界的に医療インフラへの投資を増加させることで、特に市場の拡大を加速させました。しかし、人工肺デバイスとそのメンテナンスに関連する非常に高いコスト、製品発売を遅らせかねない複雑な規制承認プロセス、これらの侵襲的処置に関連する出血、感染、血栓症などの重大な合併症リスクなど、市場成長はかなりの抑制要因に直面しています。高度な人工肺システムの操作訓練を受けた熟練した医療専門家が不足していることに加え、新興国市場ではこれらのデバイスの入手可能性が限られていることが、市場浸透をさらに制約しています。とはいえ、現在進行中の生体工学の研究開発、特に患者ケアに革命をもたらす可能性のある埋め込み型人工肺やウェアラブルデバイスの開発には、大きなビジネスチャンスが存在します。

予測モニタリングと自動調整のための人工知能と機械学習技術の統合は、市場拡大の有望な道筋を示す一方、新興市場における医療支出の増加と高度な呼吸ケアソリューションに対する意識の高まりは、新たな成長機会を生み出します。医療機器メーカーと医療機関の戦略的パートナーシップ、およびクリティカルケアのインフラ開拓を支援する政府のイニシアチブは、人工肺分野の持続的な市場成長と技術革新を促進すると予想されます。

当レポートの主な特徴

  • 当レポートは、世界の人工肺市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
  • また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の人工肺市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
  • 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
  • 「世界の人工肺市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
  • 利害関係者は、世界の人工肺市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学・規制・動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 企業合併・買収 (M&A) のシナリオ
  • 業界動向

第4章 世界の人工肺市場：製品種類別（2020～2032年）

  • 体外膜型人工肺（ECMO）システム
  • 体外人工肺
  • 埋め込み型人工肺
  • その他（酸素化装置）

第5章 世界の人工肺市場：技術別（2020～2032年）

  • 灌流システム
  • 膜酸素化技術
  • マイクロ流体酸素化装置
  • バイオハイブリッドシステム
  • ポンプレスガス交換システム
  • その他（3Dプリント人工肺構造など）

第6章 世界の人工肺市場：可搬性別（2020～2032年）

  • 据置型システム
  • ポータブルシステム
  • ウェアラブルシステム

第7章 世界の人工肺市場：用途別（2020～2032年）

  • 肺移植サポート（Bridge-to-Transplant）
  • 急性呼吸窮迫症候群（ARDS）
  • 慢性呼吸器疾患（COPD、肺高血圧症、嚢胞性線維症）
  • その他（冠動脈バイパス移植手術など）

第8章 世界の人工肺市場：患者の種類別（2020～2032年）

  • 新生児
  • 小児科
  • アダルト

第9章 世界の人工肺市場：エンドユーザー別（2020～2032年）

  • 病院
  • 移植センター
  • 外来手術センター
  • 救急・外傷センター
  • 在宅医療（ウェアラブルデバイス用）
  • その他（研究機関等）

第10章 世界の人工肺市場：地域別（2020～2032年）

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第11章 競合情勢

  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • ALung Technologies, Inc.
  • Breethe, Inc.
  • Miromatrix Medical Inc.
  • Abiomed, Inc.
  • Cyanagen Srl
  • Nipro Corporation
  • Hemovent GmbH

第12章 アナリストの提言

  • 「運命の輪」
  • アナリストの見解
  • Coherent Opportunity Map (COM)

第13章 参考文献と調査手法

  • 参考文献
  • 分析手法
  • Coherent Market Insightsについて
目次
Product Code: CMI8255

Artificial Lung Market is estimated to be valued at USD 2.10 Bn in 2025 and is expected to reach USD 4.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.10% 2032 Value Projection: USD 4.12 Bn

The global artificial lung market represents a critical segment within the broader medical device industry, focusing on advanced life-support technologies designed to temporarily or permanently replace natural lung function in patients with severe respiratory conditions.

Artificial lungs, also known as extracorporeal membrane oxygenation (ECMO) systems or mechanical lung support devices, serve as vital therapeutic solutions for patients suffering from acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary embolism, and other life-threatening respiratory failures. These sophisticated biomedical devices function by oxygenating blood and removing carbon dioxide outside the body, effectively performing the gas exchange function typically handled by healthy lungs.

The market encompasses various technological approaches, including membrane oxygenators, artificial lung implants, and wearable artificial lung systems, each designed to address specific patient needs and clinical scenarios. With the increasing prevalence of respiratory diseases globally, aging populations, and the recent impact of respiratory pandemics, the artificial lung market has gained significant attention from healthcare providers, medical device manufacturers, and investors seeking innovative solutions to address critical care challenges and improve patient outcomes in intensive care settings.

Market Dynamics

The global artificial lung market is primarily driven by the escalating prevalence of respiratory diseases worldwide, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, and pulmonary fibrosis, which collectively affect millions of patients globally and create substantial demand for advanced respiratory support technologies. The aging global population significantly contributes to market growth, as elderly individuals are more susceptible to respiratory complications and require intensive care interventions, while technological advancements in biocompatible materials, miniaturization, and improved gas exchange efficiency have enhanced the performance and safety profiles of artificial lung systems.

The COVID-19 pandemic has particularly accelerated market expansion by highlighting the critical need for respiratory support devices and increasing healthcare infrastructure investments globally. However, market growth faces considerable restraints, including the extremely high costs associated with artificial lung devices and their maintenance, complex regulatory approval processes that can delay product launches, and the significant risk of complications such as bleeding, infection, and thrombosis associated with these invasive procedures. The shortage of skilled healthcare professionals trained in operating sophisticated artificial lung systems, coupled with limited availability of these devices in developing regions, further constrains market penetration. Nevertheless, substantial opportunities exist through ongoing research and development in bioengineering, particularly in developing implantable artificial lungs and wearable devices that could revolutionize patient care.

The integration of artificial intelligence and machine learning technologies for predictive monitoring and automated adjustments presents promising avenues for market expansion, while increasing healthcare expenditure in emerging markets and growing awareness about advanced respiratory care solutions create new growth opportunities. Strategic partnerships between medical device manufacturers and healthcare institutions, along with government initiatives supporting critical care infrastructure development, are expected to drive sustained market growth and innovation in the artificial lung sector.

Key Features of the Study

  • This report provides in-depth analysis of the global artificial lung market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global artificial lung market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, ALung Technologies, Inc., Breethe, Inc., Miromatrix Medical Inc., Abiomed, Inc., Cyanagen Srl, Nipro Corporation, and Hemovent GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global artificial lung market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial lung market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Extracorporeal Membrane Oxygenation (ECMO) Systems
    • Veno-Arterial (VA) ECMO
    • Veno-Venous (VV) ECMO
    • Paracorporeal Artificial Lungs
    • Pumpless Paracorporeal Devices
    • Pump-Assisted Paracorporeal Devices
    • Implantable Artificial Lungs
    • Intrathoracic Devices
    • Vascular Graft-Integrated Devices
    • Others (Oxygenators)
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Perfusion Systems
    • Membrane Oxygenation Technology
    • Microfluidic Oxygenators
    • Biohybrid Systems
    • Pumpless Gas Exchange Systems
    • Others (3D-Printed Artificial Lung Constructs, etc.)
  • Portability Insights (Revenue, USD Bn, 2020 - 2032)
    • Stationary Systems
    • Portable Systems
    • Wearable Systems
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Lung Transplant Support (Bridge-to-Transplant)
    • Acute Respiratory Distress Syndrome (ARDS)
    • Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
    • Others (Coronary Artery Bypass Grafting, etc.)
  • Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Neonates
    • Pediatric
    • Adult
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Transplant Centers
    • Ambulatory Surgical Centers
    • Emergency and Trauma Centers
    • Home Care Settings (for wearable devices)
    • Others (Research Institutes, etc.)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic plc
    • Getinge AB
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • ALung Technologies, Inc.
    • Breethe, Inc.
    • Miromatrix Medical Inc.
    • Abiomed, Inc.
    • Cyanagen Srl
    • Nipro Corporation
    • Hemovent GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Artificial Lung Market, By Product Type
    • Global Artificial Lung Market, By Technology
    • Global Artificial Lung Market, By Portability
    • Global Artificial Lung Market, By Application
    • Global Artificial Lung Market, By Patient Type
    • Global Artificial Lung Market, By End User
    • Global Artificial Lung Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Artificial Lung Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Extracorporeal Membrane Oxygenation (ECMO) Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Veno-Arterial (VA) ECMO
      • Veno-Venous (VV) ECMO
  • Paracorporeal Artificial Lungs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Pumpless Paracorporeal Devices
      • Pump-Assisted Paracorporeal Devices
  • Implantable Artificial Lungs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Intrathoracic Devices
      • Vascular Graft-Integrated Devices
  • Others (Oxygenators)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Lung Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Membrane Oxygenation Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microfluidic Oxygenators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biohybrid Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pumpless Gas Exchange Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (3D-Printed Artificial Lung Constructs, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Lung Market, By Portability, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stationary Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Portable Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wearable Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Lung Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lung Transplant Support (Bridge-to-Transplant)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Acute Respiratory Distress Syndrome (ARDS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Coronary Artery Bypass Grafting, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Lung Market, By Patient Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Neonates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Lung Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transplant Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emergency and Trauma Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings (for wearable devices)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Artificial Lung Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Getinge AB
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Medical Care AG & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ALung Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breethe, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Miromatrix Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abiomed, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cyanagen Srl
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nipro Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hemovent GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us